Breaking News

Home / Clinical Trials / Coronavirus (2019-nCoV) / Molnupiravir (Drug) / Merck says its antiviral pill is less effective in a final analysis.

Merck says its antiviral pill is less effective in a final analysis.

November 26, 2021 , ,

By BY REBECCA ROBBINS from NYT Science https://ift.tt/3cRWljD

No comments

Subscribe to: Post Comments ( Atom )